Complicated Urinary Tract Infection (DBCOND0040639)

Identifiers

Synonyms
Complicated Urinary Tract Infection; Cuti / Urinary Tract Infection (cUTI) / Complicated Urinary Tract Infections (cUTI) / Urinary Tract Infection, Complicated / Complicated Urinary Tract Infections (cUTIs) / Complicated UTI / Urinary Tract Infection Complicated / Complicated Urinary Tract Infections / Complicated Urinary Tract Infection (cUTI) / CUTI / Complicated Urinary Infection / Complicated urinary tract infection / Urinary tract infection (& [NOS]) / (Urethral and/or urinary disorders NOS) or (urinary infection NOS) / Urinary infection NOS (disorder) / Urinary infection / UTI / Urinary tract infection, site not specified NOS (disorder) / Urinary tract infection, site not specified / Urinary tract infection: [site not specified] or [recurrent] / Urinary tract infection NOS / Urinary tract infections / Infection urinary tract / Urinary tract infectious disease (disorder) / Urinary tract infection

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Avibactam
A non-β-lactam β-lactamase inhibitor used in combination with ceftazidime for the treatment of complicated intra-abdominal infections, complicated urinary tract infections, and hospital or ventilator-acquired pneumonia.
Cefepime
A fourth-generation cephalosporin antibiotic used in the treatment of infections caused by susceptible bacteria, such as pneumonia, urinary tract infections, and skin infections.
Cefiderocol
A cephalosporin antibiotic used in complicated urinary tract infections.
Ceftazidime
An injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others.
Cilastatin
A renal dehydropeptidase inhibitor used to prevent degradation of imipenem. Both medications are used together to treat a variety of infections.
Ciprofloxacin
A second generation fluoroquinolone used to treat various susceptible bacterial infections.
Doripenem
An antibiotic of the penem class used to treat complicated intra-abdominal and urinary tract infections.
Enmetazobactam
A beta-lactamase inhibitor used to treat complicated urinary tract infections in combination with cefepime.
Fosfomycin
A broad spectrum antibiotic used to treat uncomplicated urinary tract infections.
Imipenem
A carbapenem antibiotic normally administered with cilastatin to treat a variety of infections.
Ofloxacin
An antibacterial agent used for the treatment of bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.
Plazomicin
An aminoglycoside antibiotic used to treat complicated urinary tract infections.
Relebactam
A beta-lactamase inhibitor used to prevent hydrolysis of beta-lactam antibiotics, leading to increased effectiveness.
Tazobactam
A beta lactamase inhibitor administered with antibiotics such as piperacillin and ceftolozane to prevent their degradation, resulting in increased efficacy.
Teicoplanin
A glycopeptide antibiotic with a similar mechanism of action and spectrum of activity to vancomycin used to treat various infections caused by gram-positive bacteria.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT01978938
Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infectionstreatment3completed
NCT04476407
Pharmacokinetics of Benapenem in Subjects With Renal Impairmenttreatment1completed
NCT02714595
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogenstreatment3completed
NCT04335539
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participantstreatment2completed
NCT04215991
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participantstreatment2recruiting
NCT03377426
LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)No drug interventionsbasic_science2withdrawn
NCT03032510
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infectionstreatment3completed
NCT03357614
Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adultstreatment3completed
NCT02497781
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs)treatment2completed
NCT02168946
Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adultstreatment3completed
NCT03477422
CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteriatreatment3completed
NCT02166476
Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and APtreatment3completed
NCT02753946
Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infectionstreatment2 / 3completed
NCT05826990
A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTItreatment2recruiting
NCT00690378
Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infectionstreatment2completed
NCT04979806
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)treatment3recruiting
NCT04076436
Efficacy of Intravenous Fosfomycin in the Treatment of Complicated Urinary in Real-life Conditions.No drug interventionsNot AvailableNot Availableunknown_status
NCT01345929
Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritistreatment3completed
NCT03788967
Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)treatment3completed
NCT05733104
A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in KoreaNo drug interventionsNot AvailableNot Availablerecruiting
NCT03630081
Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)treatment3not_yet_recruiting
NCT03230838
MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)treatment2completed
NCT03293485
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)treatment3completed
NCT05674032
Bacterial Metallophores in the Diagnosis of Acute PyelonephritisNo drug interventionsNot AvailableNot Availablerecruiting
NCT01096849
A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP)treatment2completed
NCT05385536
Evaluating UTI Outcomes in at Risk PopulationsNo drug interventionsNot AvailableNot Availablecompleted
NCT05060419
Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infectionstreatment2unknown_status
NCT04682834
Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract InfectionNot AvailableNot Availableno_longer_available
NCT00921024
Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infectionstreatment2completed
NCT02024282
Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary CareNo drug interventionsdiagnosticNot Availablecompleted
NCT04876131
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Childrentreatment4recruiting
NCT02486627
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)treatment3completed
NCT02728089
Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)treatment3completed
NCT03445195
Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infectionstreatment2completed
NCT05905055
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacteralestreatment3recruiting
NCT05887908
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritistreatment3recruiting
NCT01644643
Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogenstreatment3completed
NCT02420366
Study of Cases of Serious Infections Due to Carbapenem-Resistant EnterobacteriaceaeNo drug interventionsNot AvailableNot Availablecompleted
NCT02364284
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAPNo drug interventionsNot AvailableNot Availablecompleted
NCT00245791
Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of Timetreatment4terminated